Su Ann Ho

ResearcherPublications, citations & collaboration network

Su Ann Ho is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 11 works, 140 citations, an h-index of 5 and an i10-index of 4.

Works

140

Citations

h-index

i10-index

IDs:OpenAlex

How has Su Ann Ho's publication output changed over time?

ScholarIQpublication output · 2016–2025

Output grew0% over the shown period — from 1 works in 2016 to 1 in 2025.

20162020202120232025

What are the most-cited papers on Su Ann Ho?

ScholarIQmost cited works

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021

Maggie Chau, Kathryn Daveson, Jan‐Willem C. Alffenaar, Amanda Gwee, Su Ann Ho, Deborah Marriott, Jason A. Trubiano, Jessie Zhao, Jason A. Roberts

Internal Medicine Journal. 202169 CitationsOPEN ACCESS

Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study

Anat Stern, Carolyn D. Alonso, Carolina García‐Vidal, Celia Cardozo, Monica A. Slavin, Michelle K. Yong, Su Ann Ho, Seema Mehta Steinke, Robin K. Avery, Philipp Koehler, Christof Scheid, Oliver A. Cornely, Johan Maertens, Yasmine Abi Aad, David J. Epstein, Genovefa A. Papanicolaou, Dionysios Neofytos

S124275759. 202126 CitationsOPEN ACCESS

Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring

Su Ann Ho, Monica A. Slavin, Jason A. Roberts, Michelle K. Yong

S185628608. 202021 Citations

Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation

Diana Wong, Su Ann Ho, Ana Domazetovska, Michelle K. Yong, William D. Rawlinson

S67076826. 202313 Citations

In-flight transmission of measles: Time to update the guidelines?

Lyn‐li Lim, Su Ann Ho, Mary O’Reilly

S154451576. 20165 CitationsOPEN ACCESS